首页> 外文期刊>Human Reproduction >Clinical outcome with half-dose depot triptorelin is the same as reduced-dose daily buserelin in a long protocol of controlled ovarian stimulation for ICSI/embryo transfer: a randomized double-blind clinical trial (NCT00461916)
【24h】

Clinical outcome with half-dose depot triptorelin is the same as reduced-dose daily buserelin in a long protocol of controlled ovarian stimulation for ICSI/embryo transfer: a randomized double-blind clinical trial (NCT00461916)

机译:在ICSI /胚胎移植的长期控制卵巢刺激方案中,半剂量雷公藤多酚的临床结果与每日减少剂量的布塞林相同:一项随机双盲临床试验(NCT00461916)

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND Traditional doses of depot GnRH agonist may be excessive for ovarian stimulation. We compared half-dose depot triptorelin (Group I) with reduced-dose daily buserelin (Group II) in a long protocol ICSI/embryo transfer through a double-blind randomized clinical trial.
机译:背景技术传统的长效GnRH激动剂剂量对于卵巢刺激可能过量。通过一项双盲随机临床试验,在长期方案ICSI /胚胎移植中,我们将半剂量的曲普瑞林(I组)与每日减少剂量的布塞林(II组)进行了比较。

著录项

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号